Pure Global
NCT06240598

A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy

Identification of Markers of Resistance During Frontline Therapy and Maintenance
Memorial Sloan Kettering Cancer Center·Phase 2·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Ovarian Cancer
Drug/Device/Intervention
Second Look Laparoscopy
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Memorial Sloan Kettering Cancer Center
Location
Basking Ridge,Middletown,Montvale,Commack,Harrison,New York,Uniondale, United States of America
Timeline & enrollment
Phase
Phase 2
Start date
Jan 26, 2024
End date
Jan 01, 2026
Enrollment
80 participants
Primary outcome

minimal residual disease (MRD) status

Summary

The researchers are doing this study to look at the health outcomes of people with advanced
 ovarian cancer who have a second look laparoscopy (SLL) after they complete their first
 course of chemotherapy. The researchers will compare the health outcomes of people who have
 minimal residual disease (MRD-small amounts of cancer cells in the body after a person
 receives treatment) at the time of SLL with the health outcomes of people who do not have MRD
 at the time of SLL. The researchers are also doing this study to determine if SLL is safe and
 practical (feasible) in people with advanced ovarian cancer who have completed the first
 course of therapy for their disease.

ICD-10 classifications
Malignant neoplasm of ovarySecondary malignant neoplasm of ovaryBenign neoplasm of ovaryOvarian pregnancyOvarian dysfunction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06240598
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06240598 through Pure Global AI's free database. This Phase 2 trial is sponsored by Memorial Sloan Kettering Cancer Center and is currently Recruiting. The study focuses on Ovarian Cancer. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.